Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116081768> ?p ?o ?g. }
- W2116081768 endingPage "893" @default.
- W2116081768 startingPage "887" @default.
- W2116081768 abstract "1 Neuropathy is a frequently diagnosed complication of diabetes mellitus. Effective pharmacotherapy is not available. 2 The spontaneously diabetic BB/Wor rats develop secondary complications like neuropathy as do human diabetic patients. 3 BB/Wor rats treated with insulin via a subcutaneous implant show a significant impairment of sensory and motor nerve conduction velocity 6 weeks after the onset of diabetes mellitus. 4 Intraperitoneal treatment of diabetic BB/Wor rats with the Ca2+ antagonist, nimodipine (20 mg kg−1), from week 6 onwards every 48 h for a period of 6 weeks resulted in a significant increase of sensory and motor nerve conduction velocity. 5 Twelve weeks after the onset of diabetes mellitus BB/Wor rats show a 40% impairment of sciatic nerve blood flow as compared to the non-diabetic age-matched controls. Treatment with nimodipine (20 mg kg−1) from week 6 onwards significantly increased the sciatic nerve blood flow as compared to placebo-treated diabetic BB/Wor rats. 6 The adrenergic responsiveness of the vasa nervorum of the sciatic nerve to tyramine and phenylephrine was investigated as a parameter for autonomic neuropathy. 7 The fact that nimodipine treatment restored the reduced response to tyramine independently of the reduced postsynaptic phenylephrine responsiveness indicates that nimodipine improves adrenergic responsiveness mainly at the presynaptic level." @default.
- W2116081768 created "2016-06-24" @default.
- W2116081768 creator A5000444981 @default.
- W2116081768 creator A5015881263 @default.
- W2116081768 creator A5028587177 @default.
- W2116081768 creator A5066510552 @default.
- W2116081768 creator A5068335403 @default.
- W2116081768 creator A5075093239 @default.
- W2116081768 creator A5088575640 @default.
- W2116081768 date "1994-03-01" @default.
- W2116081768 modified "2023-09-29" @default.
- W2116081768 title "Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat" @default.
- W2116081768 cites W1550293732 @default.
- W2116081768 cites W1560615204 @default.
- W2116081768 cites W1931874897 @default.
- W2116081768 cites W1963648674 @default.
- W2116081768 cites W1965126420 @default.
- W2116081768 cites W1966292269 @default.
- W2116081768 cites W1974785946 @default.
- W2116081768 cites W1975879524 @default.
- W2116081768 cites W1977080816 @default.
- W2116081768 cites W1984623452 @default.
- W2116081768 cites W1992290767 @default.
- W2116081768 cites W1998201848 @default.
- W2116081768 cites W2001414990 @default.
- W2116081768 cites W2022268466 @default.
- W2116081768 cites W2023867987 @default.
- W2116081768 cites W2024841470 @default.
- W2116081768 cites W2025933768 @default.
- W2116081768 cites W2026710409 @default.
- W2116081768 cites W2032272151 @default.
- W2116081768 cites W2032624189 @default.
- W2116081768 cites W2033314430 @default.
- W2116081768 cites W2038233386 @default.
- W2116081768 cites W2040644761 @default.
- W2116081768 cites W2047007984 @default.
- W2116081768 cites W2052749603 @default.
- W2116081768 cites W2059688625 @default.
- W2116081768 cites W2065395180 @default.
- W2116081768 cites W2068013747 @default.
- W2116081768 cites W2069443337 @default.
- W2116081768 cites W2071172184 @default.
- W2116081768 cites W2074328785 @default.
- W2116081768 cites W2074406150 @default.
- W2116081768 cites W2077395449 @default.
- W2116081768 cites W2081138541 @default.
- W2116081768 cites W2084477518 @default.
- W2116081768 cites W2084878288 @default.
- W2116081768 cites W2085546592 @default.
- W2116081768 cites W2090809239 @default.
- W2116081768 cites W2099604717 @default.
- W2116081768 cites W2103776961 @default.
- W2116081768 cites W2106920242 @default.
- W2116081768 cites W2116632151 @default.
- W2116081768 cites W2124008099 @default.
- W2116081768 cites W2126498174 @default.
- W2116081768 cites W2130815520 @default.
- W2116081768 cites W2145954727 @default.
- W2116081768 cites W2146394102 @default.
- W2116081768 cites W2160337365 @default.
- W2116081768 cites W2161003385 @default.
- W2116081768 cites W2164499895 @default.
- W2116081768 cites W2292512265 @default.
- W2116081768 cites W2317146405 @default.
- W2116081768 cites W2340223668 @default.
- W2116081768 cites W3022440034 @default.
- W2116081768 cites W31449759 @default.
- W2116081768 cites W4244093293 @default.
- W2116081768 cites W4244126873 @default.
- W2116081768 cites W4245390531 @default.
- W2116081768 cites W4245991255 @default.
- W2116081768 cites W4248444026 @default.
- W2116081768 cites W4248971237 @default.
- W2116081768 cites W4250584788 @default.
- W2116081768 doi "https://doi.org/10.1111/j.1476-5381.1994.tb14821.x" @default.
- W2116081768 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1910095" @default.
- W2116081768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8019766" @default.
- W2116081768 hasPublicationYear "1994" @default.
- W2116081768 type Work @default.
- W2116081768 sameAs 2116081768 @default.
- W2116081768 citedByCount "44" @default.
- W2116081768 countsByYear W21160817682013 @default.
- W2116081768 countsByYear W21160817682014 @default.
- W2116081768 countsByYear W21160817682017 @default.
- W2116081768 countsByYear W21160817682020 @default.
- W2116081768 crossrefType "journal-article" @default.
- W2116081768 hasAuthorship W2116081768A5000444981 @default.
- W2116081768 hasAuthorship W2116081768A5015881263 @default.
- W2116081768 hasAuthorship W2116081768A5028587177 @default.
- W2116081768 hasAuthorship W2116081768A5066510552 @default.
- W2116081768 hasAuthorship W2116081768A5068335403 @default.
- W2116081768 hasAuthorship W2116081768A5075093239 @default.
- W2116081768 hasAuthorship W2116081768A5088575640 @default.
- W2116081768 hasBestOaLocation W21160817682 @default.
- W2116081768 hasConcept C126322002 @default.
- W2116081768 hasConcept C134018914 @default.
- W2116081768 hasConcept C170493617 @default.
- W2116081768 hasConcept C179253579 @default.